15-Minute iron shot could beat anemia fast

NCT ID NCT01374919

Completed Disease control Sponsor: Auerbach Hematology Oncology Associates P C Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a single 15-minute infusion of ferumoxytol, a type of intravenous iron, in 60 people with iron deficiency anemia who couldn't take oral iron. The goal was to see if this quick dose safely raises hemoglobin levels. Researchers checked for side effects right after the infusion and during follow-up calls and visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ferumoxytol (intravenous iron)
What this could lead to: If successful, this could offer a quicker, more convenient way to treat iron deficiency anemia with a single 15-minute infusion.
What could go wrong: This is a small, completed trial with only 60 participants, so results may not apply to everyone. There is a risk of allergic reactions to ferumoxytol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRON DEFICIENCY ANEMIA

Contacts and locations

Locations

Auerbach Hematology and Oncology

Baltimore, Maryland, 21237, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.